Latest Competition News

Arcadia Minerals announces key leadership departures and a strategic pivot towards gold and critical minerals acquisitions, alongside planned drilling at its promising TVC Project in Namibia.

Dalrymple Bay Infrastructure has secured $1.07 billion in new loan facilities, slashing its borrowing costs and extending debt maturity while maintaining its investment grade rating.

Emeco Group reveals a robust FY25 with $785 million revenue, nearly half from its expanding maintenance services, underpinned by advanced asset management technology and a strategic push into new sectors.

Immutep has struck a strategic licensing deal with Dr. Reddy’s, granting rights to commercialise its novel cancer immunotherapy Eftilagimod Alfa across key emerging markets. The agreement includes a $20 million upfront payment and potential milestones exceeding $349 million.

Southern Palladium Limited has completed the second tranche of its capital raising, issuing over 11.5 million shares to raise A$12.74 million following shareholder approval.

Stonehorse Energy’s first well in Alberta’s Ellerslie reservoir is producing ahead of schedule and below budget, prompting plans for three more wells in 2026 to deepen its foothold in Western Canada.

Norwood Systems has successfully raised $650,000 through an oversubscribed share placement, aiming to fuel its market growth and strategic partnerships in AI-driven voice communication.

Antares Metals Limited (ASX, AM5) has announced a significant acquisition of gold and base metals assets in Western Australia, positioning itself for a maiden drilling campaign in early 2026.

Bass Oil has signed a binding three-year gas sales agreement with Origin Energy for supply from the Vanessa Gas Project, marking a strategic entry into the East Coast Gas Market starting in 2026.

APA Group’s BBB credit rating is affirmed by S&P with a key modification that expands its borrowing power by over $1 billion, positioning the energy infrastructure giant for accelerated growth.

Artrya Limited has landed a significant three-year commercial agreement with Northeast Georgia Health System, marking its second U.S. customer for the AI-powered Salix platform. This deal accelerates Artrya’s footprint in cardiovascular diagnostics across a major U.S. health network.

Imugene Limited has received positive feedback from the FDA, aligning key requirements to progress its azer-cel therapy into a pivotal clinical trial, underscoring its growing promise in blood cancer treatment.